FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003404001> ?p ?o ?g. }

• W2003404001 endingPage "1080" @default.
• W2003404001 startingPage "1061" @default.
• W2003404001 abstract "The aim of the present study was to investigate transfersomes as a transdermal delivery system for the poorly soluble drug, sertraline, in order to overcome the troubles associated with its oral delivery. Different transfersomal formulations were prepared with non-ionic surfactant (span 80), soya lecithin, and carbopol 940 by the rotary evaporation sonication method. The prepared formulations were characterized for light microscopy, particle size analysis, drug entrapment, turbidity, drug content, rheological studies, in vitro release, ex vivo permeation, and stability studies. The optimized formulation was evaluated for in vivo studies using the modified forced swim model test. FTIR studies showed compatibility of the drug with excipients. The result revealed that sertraline in all of the formulations was successfully entrapped with uniform drug content. Transfersomal gel containing 1.6% of the drug and 20% of span 80 was concluded to be the optimized formulation (EL-SP4), as it showed maximum drug entrapment (90.4±0.15%) and cumulative percent drug release(73.8%). The ex vivo permeation profile of EL-SP4 was compared with the transfersomal suspension, control gel, and drug solution. The transfersomal gel showed a significantly higher (p<0.05) cumulative amount of drug permeation and flux along with lower lag time than the drug solution and drug gel. It also owed to better applicability due to the higher viscosity imparted by the gel rather than the transfersomal suspension, and no skin irritation was observed. The modified forced swim test in mice revealed that the transfersomal gel had better antidepressant activity as compared to the control gel. Thus, the study substantiated that the transfersomal gel can be used as a feasible alternative to the conventional formulations of sertraline with advanced permeation characteristics for transdermal application." @default.
• W2003404001 created "2016-06-24" @default.
• W2003404001 creator A5009420630 @default.
• W2003404001 creator A5046536902 @default.
• W2003404001 creator A5077496242 @default.
• W2003404001 creator A5082597842 @default.
• W2003404001 date "2012-01-01" @default.
• W2003404001 modified "2023-10-12" @default.
• W2003404001 title "Transfersomes: A Novel Vesicular Carrier for Enhanced Transdermal Delivery of Sertraline: Development, Characterization, and Performance Evaluation" @default.
• W2003404001 cites W1566346393 @default.
• W2003404001 cites W1967267374 @default.
• W2003404001 cites W1972913560 @default.
• W2003404001 cites W1973706034 @default.
• W2003404001 cites W1983513996 @default.
• W2003404001 cites W1986557490 @default.
• W2003404001 cites W2033381869 @default.
• W2003404001 cites W2051887903 @default.
• W2003404001 cites W2054872615 @default.
• W2003404001 cites W2057096079 @default.
• W2003404001 cites W2059875487 @default.
• W2003404001 cites W2060879575 @default.
• W2003404001 cites W2061491491 @default.
• W2003404001 cites W206156325 @default.
• W2003404001 cites W2064694508 @default.
• W2003404001 cites W2069516100 @default.
• W2003404001 cites W2074937552 @default.
• W2003404001 cites W2076185097 @default.
• W2003404001 cites W2085205359 @default.
• W2003404001 cites W2095549286 @default.
• W2003404001 doi "https://doi.org/10.3797/scipharm.1208-02" @default.
• W2003404001 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3528046" @default.
• W2003404001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23264950" @default.
• W2003404001 hasPublicationYear "2012" @default.
• W2003404001 type Work @default.
• W2003404001 sameAs 2003404001 @default.
• W2003404001 citedByCount "121" @default.
• W2003404001 countsByYear W20034040012012 @default.
• W2003404001 countsByYear W20034040012013 @default.
• W2003404001 countsByYear W20034040012014 @default.
• W2003404001 countsByYear W20034040012015 @default.
• W2003404001 countsByYear W20034040012016 @default.
• W2003404001 countsByYear W20034040012017 @default.
• W2003404001 countsByYear W20034040012018 @default.
• W2003404001 countsByYear W20034040012019 @default.
• W2003404001 countsByYear W20034040012020 @default.
• W2003404001 countsByYear W20034040012021 @default.
• W2003404001 countsByYear W20034040012022 @default.
• W2003404001 countsByYear W20034040012023 @default.
• W2003404001 crossrefType "journal-article" @default.
• W2003404001 hasAuthorship W2003404001A5009420630 @default.
• W2003404001 hasAuthorship W2003404001A5046536902 @default.
• W2003404001 hasAuthorship W2003404001A5077496242 @default.
• W2003404001 hasAuthorship W2003404001A5082597842 @default.
• W2003404001 hasBestOaLocation W20034040011 @default.
• W2003404001 hasConcept C104628117 @default.
• W2003404001 hasConcept C138651985 @default.
• W2003404001 hasConcept C159985019 @default.
• W2003404001 hasConcept C178790620 @default.
• W2003404001 hasConcept C185592680 @default.
• W2003404001 hasConcept C192562407 @default.
• W2003404001 hasConcept C202751555 @default.
• W2003404001 hasConcept C205679159 @default.
• W2003404001 hasConcept C26291073 @default.
• W2003404001 hasConcept C2779564620 @default.
• W2003404001 hasConcept C2779820397 @default.
• W2003404001 hasConcept C2780035454 @default.
• W2003404001 hasConcept C41625074 @default.
• W2003404001 hasConcept C43617362 @default.
• W2003404001 hasConcept C50670333 @default.
• W2003404001 hasConcept C55493867 @default.
• W2003404001 hasConcept C56918372 @default.
• W2003404001 hasConcept C58226133 @default.
• W2003404001 hasConcept C71924100 @default.
• W2003404001 hasConcept C98274493 @default.
• W2003404001 hasConceptScore W2003404001C104628117 @default.
• W2003404001 hasConceptScore W2003404001C138651985 @default.
• W2003404001 hasConceptScore W2003404001C159985019 @default.
• W2003404001 hasConceptScore W2003404001C178790620 @default.
• W2003404001 hasConceptScore W2003404001C185592680 @default.
• W2003404001 hasConceptScore W2003404001C192562407 @default.
• W2003404001 hasConceptScore W2003404001C202751555 @default.
• W2003404001 hasConceptScore W2003404001C205679159 @default.
• W2003404001 hasConceptScore W2003404001C26291073 @default.
• W2003404001 hasConceptScore W2003404001C2779564620 @default.
• W2003404001 hasConceptScore W2003404001C2779820397 @default.
• W2003404001 hasConceptScore W2003404001C2780035454 @default.
• W2003404001 hasConceptScore W2003404001C41625074 @default.
• W2003404001 hasConceptScore W2003404001C43617362 @default.
• W2003404001 hasConceptScore W2003404001C50670333 @default.
• W2003404001 hasConceptScore W2003404001C55493867 @default.
• W2003404001 hasConceptScore W2003404001C56918372 @default.
• W2003404001 hasConceptScore W2003404001C58226133 @default.
• W2003404001 hasConceptScore W2003404001C71924100 @default.
• W2003404001 hasConceptScore W2003404001C98274493 @default.
• W2003404001 hasIssue "4" @default.
• W2003404001 hasLocation W20034040011 @default.
• W2003404001 hasLocation W20034040012 @default.
• W2003404001 hasLocation W20034040013 @default.

• next